Managing Cutaneous Lymphoma during the COVID-19 Pandemic
April 12, 2020
United States Cutaneous Lymphoma Consortium (USCLC)
Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic
National Comprehensive Cancer Network (NCCN)
Short-term guidelines for managing cutaneous lymphoma during the COVID-19 pandemic
News for Patients
During this time of crisis, we applaud the many pharmaceutical companies helping. An example is Helsinn, who in the U.S. is waiving co-pays for cutaneous lymphoma patients for the durations of pandemic.